PTK2 and cancer: Given that the β4 integrin/FAK complex enables the activation of AKT- and p38MAPK-mediated signaling (Fig. 3e), the distinct role of AKT and p38MAPK in β4 integrin/FAK complex-mediated cancer malignancy was investigated.